UTI as a Cause of Urine Colour Change: From Cystitis to Pyelonephritis

How a UTI changes urine colour, smell, and clarity

A urinary tract infection (UTI) is an infection involving any part of the urinary tract: the urethra, bladder, ureters, or kidneys. The most common causative organism in healthy adults is Escherichia coli, an intestinal bacterium that ascends from the perineum into the urethra and then the bladder. Other common organisms include Klebsiella, Proteus, and Enterococcus. The CDC UTI reference covers the microbiology and antibiotic stewardship issues.

The visible changes to urine come from the body's inflammatory response. White blood cells flood into the urinary tract to fight the bacteria, producing pyuria (pus in urine), which gives a cloudy or turbid appearance. The bacteria themselves contribute to cloudiness. Microscopic blood from the inflamed urothelial lining can produce a faint pink tinge. The breakdown of bacteria and pus can produce a strong, fishy, or foul smell. The NHS cystitis guidance describes this presentation.

Cloudy, pink, or strong-smelling urine on its own does not confirm UTI. Phosphate crystals from a dairy-heavy meal can produce harmless cloudiness. Beetroot can produce pink colouring without infection. Asparagus produces a strong smell without infection. The diagnostic value of urine appearance is greatest when combined with the typical lower-tract symptom cluster: burning on urination, urgency, frequency producing small amounts, and suprapubic discomfort.

Cystitis: lower-tract UTI

Cystitis is bladder infection. The classic adult woman presentation is sudden onset (over hours, not days) of burning on urination, frequent urge producing only small amounts, urgency that is hard to defer, suprapubic discomfort, and cloudy or pink-tinged urine often with a strong smell. Typically there is no fever, no flank pain, and no vomiting in uncomplicated cystitis.

The NICE NG109 guideline on lower UTI in non-pregnant women outlines the empirical treatment pathway. For an otherwise healthy non-pregnant adult woman with the classic symptom cluster, urine culture is not required before treatment. First-line antibiotic options in the UK are typically nitrofurantoin (100 mg modified-release twice daily for three days) or trimethoprim (200 mg twice daily for three days, where local resistance allows). Course lengths are kept short to minimise resistance and side effects. Symptoms typically improve within 24-48 hours.

Many telehealth providers operate within the NICE NG109 framework and can offer prescriptions without a face-to-face visit. The clinical features that move treatment away from telehealth and toward in-person assessment include pregnancy, male sex, recurrent UTIs (more than two in six months or three in a year), known structural urinary tract abnormalities, immunocompromise, and any feature suggesting upper-tract involvement.

Pyelonephritis: upper-tract UTI

Pyelonephritis is infection of one or both kidneys. It usually arises from an ascending lower-tract infection that has not been treated promptly or has not responded to oral antibiotics. The classic presentation adds fever (usually 38°C or above), shivering or rigors, one-sided flank pain, vomiting, and the feeling of being severely unwell, on top of the lower-tract symptoms that often preceded the kidney involvement by a day or two. The Cleveland Clinic pyelonephritis reference describes the typical features.

The NICE NG111 pyelonephritis guideline outlines treatment. Most cases are treated empirically with a 7-10 day course of an antibiotic such as cefalexin, co-amoxiclav, or ciprofloxacin (with caution for tendon and CNS side effects). Severe systemic features, inability to tolerate oral medications, pregnancy, suspected urinary obstruction, immunocompromise, or failure of community treatment trigger admission for IV antibiotics, IV fluids, monitoring, and imaging where needed.

Outcomes depend critically on prompt antibiotic treatment. Untreated pyelonephritis can cause permanent kidney scarring and can progress to bloodstream infection (urosepsis), which is a leading cause of intensive care admission from the community. Our cloudy with fever page covers the triage in detail.

UTIs in special populations

Pregnancy: The NICE guidance treats even asymptomatic bacteriuria in pregnancy because of the raised risk of pyelonephritis and preterm birth. Pregnant women with UTI symptoms should be assessed promptly and have a urine culture before treatment. Antibiotic choice excludes nitrofurantoin in late pregnancy (risk of neonatal haemolysis) and trimethoprim in early pregnancy (folate antagonism).

Men: UTI in men is uncommon and warrants a search for an underlying cause: prostatic hypertrophy, prostatitis, structural abnormality, or stones. Treatment courses are longer (typically 7 days minimum) and include consideration of prostate involvement.

Children: The NICE CG54 children's UTI guideline sets out specific assessment thresholds. Fever plus offensive-smelling urine in a young child is a recognised UTI presentation. Children under three with confirmed UTI typically need imaging to exclude vesicoureteric reflux. See our children's urine colours page.

Older adults: Presentation can be atypical. New confusion, falls, reduced appetite, or general deterioration without classic urinary symptoms can be the first sign. The NHS UTI overview covers the cross-age presentation. Asymptomatic bacteriuria in older adults is common and does not always warrant treatment, per the NICE guidance.

Recurrent UTIs and prevention

Recurrent UTI is defined as two or more infections in six months or three or more in a year. The NHS cystitis guidance and Cleveland Clinic UTI reference outline preventive measures, which include drinking enough fluids, urinating after sex, wiping front to back, avoiding heavily perfumed products around the genital area, and considering vaginal oestrogen in postmenopausal women.

The evidence for cranberry products is mixed. The Cochrane review on cranberries for UTI prevention has been updated several times and shows modest benefit at best, with limitations on study quality. Probiotics have less robust evidence. Prophylactic low-dose antibiotics for recurrent UTI are sometimes used under specialist guidance but raise concerns about long-term resistance. Vaginal oestrogen (in postmenopausal women) has good evidence for reducing recurrent UTI through restoration of the vaginal microbiome and urothelial integrity.

Frequently asked questions